Overview
BioXcel Therapeutics, Inc. (Nasdaq: BTAI) is a biopharmaceutical company utilizing artificial intelligence to develop transformative medicines in neuroscience. Our wholly owned subsidiary, OnkosXcel Therapeutics, is focused on the development of medicines in immuno-oncology. The Company’s drug re-innovation approach leverages existing approved drugs and/or clinically validated product candidates together with big data and proprietary machine learning algorithms to identify new therapeutic indications.
Latest Presentation
Events
Oct 30, 2024 at 2:00 PM EDT
Latest Annual Filing
| Form | Filing date | Description | View |
|---|---|---|---|
| 10-K | Annual report which provides a comprehensive overview of the company for the past year |
View HTML EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA |
Price
Change
Volume
52 Week High
52 Week Low